TwelveStone Health Partners provides Avsola infusion treatment (view full prescribing information) in clinically supervised settings for patients with Crohn’s disease, ulcerative colitis, and certain inflammatory conditions such as rheumatoid arthritis. Care is available for both adults and pediatric patients age 6 and older across more than 30 locations in the Southeast.

Our team manages referrals, insurance verification, and prior authorizations to help you start treatment without delays. You can schedule an appointment or transfer care through our contact page, or use our location finder to choose a nearby infusion center.

Trusted Clinical Expertise

TwelveStone Health Partners combines clinical pharmacy expertise with a regional infusion network across the Southeast.

  • 30+ Southeast Locations (TN, KY, GA, MS, and VA)
  • 35-Year Heritage (Clinical pharmacy and infusion roots)
  • 62+ Infusion Medications (Broad biologic drug formulary)
  • Insurance Navigation (Prior authorization and copay support)

Contact our team today to coordinate your Avsola infusion treatment.

Understanding Avsola Infusion Treatment

Avsola (infliximab-axxq) is an IV infusion medication used to treat chronic inflammatory conditions. At TwelveStone, infusions are administered in private suites with clinical monitoring throughout each session.

This therapy is approved for several specific conditions:

  1. Moderate-to-severe Crohn’s disease and ulcerative colitis in adults and children age 6 and older.
  2. Adult rheumatoid arthritis.
  3. Psoriatic arthritis and ankylosing spondylitis.

Avsola is a biosimilar to Remicade, meaning it uses the same active ingredient (infliximab) and is held to the same FDA standards for safety and effectiveness.

Prescribing specialists or insurance requirements typically determine the switch to this medication. Our team coordinates the logistics with your doctor to handle the transition and administrative details. This allows you to focus on your health while we manage the paperwork.

Understanding Your Treatment Schedule and Visit Length

Your provider determines your specific dose and schedule based on your diagnosis, weight, and clinical response. Most patients starting Avsola infusion treatment follow a two-part plan involving an initial induction phase followed by maintenance. This phase builds medication levels in your system to address active symptoms.

Condition-Specific Frequency

For Crohn’s disease or ulcerative colitis, induction typically occurs at weeks 0, 2, and 6, followed by maintenance every 8 weeks. Rheumatoid arthritis schedules may vary, with maintenance infusions often every 4 to 8 weeks based on provider guidance.

Visit Duration and Planning

Each visit typically lasts several hours. The infusion itself takes about two hours, with additional time for check-in, IV placement, and post-infusion monitoring. Our team schedules induction appointments in advance to help maintain treatment continuity.

What to Expect During Your Infusion Visit

During your visit, our team completes check-in and medication verification. A nurse records your vitals and starts your IV in a private suite. If prescribed, pre-medications are given before the infusion begins. You are monitored throughout the session, followed by a short observation period before scheduling your next appointment.

Preparing for your visit helps you remain relaxed. We recommend following these practical steps before you arrive:

  • Drink plenty of water to stay hydrated
  • Eat a meal unless your clinician directs otherwise
  • Wear loose sleeves and comfortable layers
  • Bring a book, tablet, or phone charger

Some patients plan for a lighter schedule afterward in case of mild fatigue. Our suites provide a calm alternative to hospital settings at our local centers, featuring recliners, Wi-Fi, and refreshments. Review our Infusion Center overview or explore patient resources for more information.

Insurance Navigation and Care Coordination

Avsola infusion treatment begins with a referral from your gastroenterologist or rheumatologist. After receiving your order, our team handles intake, benefits verification, and prior authorizations. Many insurance plans follow biosimilar-first policies, which may require switching to Avsola from other therapies.

Support for Patient Access

Our coordinators manage documentation with prescribers and schedule induction doses to prevent treatment gaps. We also clarify financial expectations through these specific steps:

  • Identifying manufacturer co-pay assistance for commercially insured patients
  • Explaining out-of-pocket costs based on plan details
  • Navigating rules for government-insured patients
  • Confirming eligibility for center or home-based care

TwelveStone operates 30+ centers across the Southeast, offering treatment in private suites or through home infusion. Use our location finder to find nearby clinics or request next steps to begin the authorization process.

Frequently Asked Questions About Avsola Treatment

A formal referral or medication order from your prescribing physician is required to begin treatment. Once TwelveStone receives these orders from your specialist, our intake team manages the benefits verification and prior authorization process. Patients can coordinate the transfer of their records or start the intake process by visiting our contact page.

The medication itself is typically administered over a period of at least two hours. You should plan for your total visit to be longer to allow for check-in, IV initiation, and mandatory clinical monitoring after the infusion finishes. The first appointment usually requires additional time for the clinical team to review your history and establish treatment protocols.

Drink plenty of water in the twenty-four hours leading up to your appointment for easy IV access. We recommend wearing comfortable clothing with loose sleeves and bringing layers to stay warm in our private suites. For pediatric patients age six and older, bringing a tablet or book can help the time pass more comfortably while our nursing staff monitors the session.

Avsola is a biosimilar to Remicade, which means it is a highly similar version of the same infliximab molecule and provides the same therapeutic benefits. Insurance providers often mandate a switch to biosimilars based on their current drug formularies. Our team works with your doctor to manage this transition and reports any changes in your symptoms promptly to your specialist.

Prescribing physicians usually order screening tests for tuberculosis and hepatitis before you start therapy to identify any latent infections. These tests are essential because anti-TNF medications can affect how your immune system manages existing infections. TwelveStone adheres to the specific protocols ordered by your physician and provides professional nursing oversight during every infusion to monitor for adverse reactions.

The total cost of treatment varies based on your specific insurance coverage, deductible status, and the location where you receive care. TwelveStone coordinators verify your benefits and explain your expected out-of-pocket costs before your first session begins. We also help patients identify and apply for manufacturer co-pay assistance programs when eligible to help manage the cost of care.